Utility of real-world evidence in biosimilar development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Utility of real-world evidence in biosimilar development

Published:2024-04-17 Issue: Volume: Page:1-11
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Arani Ramin B.¹,Wang Jessie¹,Pang Dong²,Sinha Samriddhi Buxy³,Uttenreuther-Fischer Martina³,Chow Shein-Chung⁴

Affiliation:

1. Biosimilar Biostatistics, Sandoz Pharmaceuticals Inc, Princeton, New Jersey, USA

2. Data Science Staffing Solutions, IQVIA, Reading, Berkshire, UK

3. Clinical Development Unit, HEXAL AG Industriestr, Holzkirchen, Germany

4. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA

Funder

no funding associated with the work featured in this article

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543406.2024.2330217

Reference33 articles.

1. A tailored use of the mahalanobis distance matching for causal effects estimation: A simulation study

2. Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations

3. The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experiments

4. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

5. Improving Institutional Evaluation Methods: Comparing Three Evaluations Using PSM, Exact and Coarsened Exact Matching

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP